Role of ion channels in the pathophysiology of ischemic heart disease: from genetics, to molecular expression, to clinical phenotype

被引：0

作者：

Severino, Paolo ^{[1
]}

DAmati, Andrea ^{[1
]}

Lucrezia, Netti ^{[1
]}

Pucci, Maria Teresa ^{[1
]}

Mariani, Marco Valerio ^{[1
]}

Birtolo, Lucia Ilaria ^{[1
]}

De Orchi, Paolo ^{[1
]}

Cimino, Sara ^{[1
]}

Maestrini, Viviana ^{[1
]}

Mancone, Massimo ^{[1
]}

Fedele, Francesco ^{[1
]}

Miraldi, Fabio ^{[1
]}

Infusino, Fabio ^{[1
]}

Palmirotta, Raffaele ^{[2
]}

Lovero, Domenica ^{[2
]}

Silvestris, Franco ^{[2
]}

Caputo, Viviana ^{[3
]}

Pizzuti, Antonio ^{[3
]}

机构：

[1] Sapienza Univ Rome, Dept Clin Internal Anaesthesiol & Cardiovasc Sci, Rome, Italy

[2] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Sect Clin & Mol Oncol, Bari, Italy

[3] Sapienza Univ Rome, Policlin Umberto I Hosp, Dept Expt Med, Rome, Italy

来源：

EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0N期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

538

引用

页码：N110 / N110

页数：1

共 50 条

[21] Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease A Consensus Statement From the American Heart Association
Mieres, Jennifer H.
Gulati, Martha
Merz, Noel Bairey
Berman, Daniel S.
Gerber, Thomas C.
Hayes, Sharonne N.
Kramer, Christopher M.
Min, James K.
Newby, L. Kristin
Nixon, J. V.
Srichai, Monvadi B.
Pellikka, Patricia A.
Redberg, Rita F.
Wenger, Nanette K.
Shaw, Leslee J.
CIRCULATION, 2014, 130 (04) : 350 - 379
[22] Immunologic aspects of asthma: from molecular mechanisms to disease pathophysiology and clinical translation
Xie, Cong
Yang, Jingyan
Gul, Aman
Li, Yifan
Zhang, Rui
Yalikun, Maimaititusun
Lv, Xiaotong
Lin, Yuhan
Luo, Qingli
Gao, Huijuan
FRONTIERS IN IMMUNOLOGY, 2024, 15
[23] Complementary Role of Coronary Microcirculatory Dysfunction and Angiographic Stenosis to Phenotype Symptomatic Patients with Ischemic Heart Disease
Christensen, Thomas
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[24] Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials
Drygalski, Krzysztof
Fereniec, Eliza
Korycinski, Krzysztof
Chomentowski, Andrzej
Kielczewska, Aleksandra
Odrzygozdz, Cezary
Modzelewska, Beata
EXPERIMENTAL GERONTOLOGY, 2018, 113 : 36 - 47
[25] Role of sulodexide, low-molecular heparin, in secondary prevention of ischemic heart disease
Aronov, DM
Bubnova, MG
Zykova, TP
Vasilyeva, EY
KARDIOLOGIYA, 1995, 35 (11) : 24 - 29
[26] The role of percutaneous revascularization in the treatment of ischemic heart disease - Insights from published reports and randomized clinical trials
Levine, GN
Nadir, M
CHEST, 1997, 112 (03) : 805 - 821
[27] Mechanisms of Disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease
Ian F Godsland
Desmond G Johnston
Nishi Chaturvedi
Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 530 - 538
[28] Mechanisms of Disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease
Godsland, Ian F.
Johnston, Desmond G.
Chaturvedi, Nishi
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (07): : 530 - 538
[29] Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis
Frank L. Dini
Nicola Riccardo Pugliese
Pietro Ameri
Umberto Attanasio
Roberto Badagliacca
Michele Correale
Valentina Mercurio
Carlo Gabriele Tocchetti
Piergiuseppe Agostoni
Alberto Palazzuoli
Heart Failure Reviews, 2023, 28 : 757 - 766
[30] Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis
Dini, Frank L.
Pugliese, Nicola Riccardo
Ameri, Pietro
Attanasio, Umberto
Badagliacca, Roberto
Correale, Michele
Mercurio, Valentina
Tocchetti, Carlo Gabriele
Agostoni, Piergiuseppe
Palazzuoli, Alberto
HEART FAILURE REVIEWS, 2023, 28 (04) : 757 - 766

← 1 2 3 4 5 →